The company has retained Agoracom for their online investor relation's initiatives. Pursuant to the terms of the Agreement, the company will issue common shares equal in value to
Please find more information on Agoracom at www.agoracom.com.
In addition, after careful evaluation of medicinal marijuana opportunities in
The company's current capital structure is as follows:
-- Common Shares Issued and Outstanding: 59,000,000 -- Warrants Outstanding: 2,506,000 at
$0.25and 3,100,000 at $0.50-- Incentive Options Outstanding: 2,800,000 at $0.25
This news release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the acquisition of an MMPR license in respect to its Southern Okanagan facility, the timing on competition of the MMPR License conditions for its
FOR FURTHER INFORMATION PLEASE CONTACT:
Supreme Pharmaceuticals Inc.Investor Relations 430 - 580 Hornby Street, Vancouver BC, V6C 3B6 (604) 674-2191 email@example.com Source: Supreme Pharmaceuticals Inc.